(Q37304750)

19 August 2017

High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS. (English)

1 reference

cytomegalovirus retinitis

19 August 2017

0 references

0 references

1 reference

Diaz-Llopis M

1

1 reference

19 August 2017

España E

2

1 reference

19 August 2017

Muñoz G

3

1 reference

19 August 2017

Navea A

4

1 reference

19 August 2017

Chipont E

5

1 reference

19 August 2017

Cano J

6

1 reference

19 August 2017

Menezo JL

7

1 reference

19 August 2017

Romero FJ

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 February 1994

1 reference

19 August 2017

5

1 reference

British Journal of Ophthalmology

inferred from page(s)

published in

1 reference

19 August 2017

78

1 reference

19 August 2017

2

1 reference

19 August 2017

120-124

1 reference

The retinal lesions of the acquired immune deficiency syndrome

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Foscarnet therapy of cytomegalovirus retinitis in AIDS.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Cytomegalovirus retinitis and response to therapy with ganciclovir

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Antiviral therapy for cytomegalovirus retinitis in AIDS with dihydroxy propoxymethyl guanine

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Treatment of Cytomegalovirus Retinitis—1992

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=504713

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

26 June 2018

1 reference

12 December 2020

Determination of phosphonoformic acid in human plasma and urine by high-performance liquid chromatography with electrochemical detection

1 reference

12 December 2020

Reversible inhibition of cytomegalovirus replication by phosphonoformate

1 reference

12 December 2020

Acquired immune deficiency syndrome. Ocular manifestations

1 reference

12 December 2020

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 reference

12 December 2020

Ophthalmic Involvement in Acquired Immunodeficiency Syndrome

1 reference

12 December 2020

Acquired immune deficiency syndrome. Pathogenic mechanisms of ocular disease

1 reference

12 December 2020

Treatment of cytomegalovirus retinopathy with ganciclovir

1 reference

12 December 2020

Treatment of cytomegalovirus retinitis with ganciclovir

1 reference

12 December 2020

Toxicity of intravitreal injection of foscarnet in the rabbit eye

1 reference

12 December 2020

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

12 December 2020

Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

12 December 2020

Identifiers

DOI

10.1136/BJO.78.2.120

1 reference

19 August 2017

1 reference

19 August 2017

1 reference